Business Standard

Ortin Laboratories Share Price

Know More

19.95-1.80 (-8.28%)

12:00 AM,12th Apr 2024

20.03-1.82 (-8.33%)

12:00 AM,12th Apr 2024

BSE : 539287


Sector : Health care

ISIN Code : INE749B01020

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 12 2024 | 12:00 AM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)


Face Value


52-WK High


52-WK High Date

12 Jun 2023

52-WK Low


52-WK Low Date

28 Mar 2024

All Time High


All Time High Date

18 Jun 2021

All Time Low


All Time Low Date

30 Mar 2020

Ortin Laboratories Ltd

Ortin Laboratories Limited was incorporated in October 1986 with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. The Company is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets capsules syrups dry powders and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations.The company offer anti arthritic drugs antibiotics chemo therapeutics analgesics and antipyretics cardiac and cardio vascular drugs anti diarroheal drugs anti depressants anti hypertensive anti aids anti tuberculosis drugs gynaecological drugs antibiotics anti diabetic antacids anti ulcer drugs anti allergics anti-cold decongestants antioxidents vitamins minerals anti bacterial drugs anti emetics anti helmenthetics nutritional supplements and protein and appetizers. They also produce dental ophthalmology pediatric diuretics dermatology psychiatry and ENT drugs. The company constructed a Factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of tablets capsules syrups dry powders & ointments. During the year 2003-04 the company started their second division of products and marketing in few states. During the year 2006-07 the company got listed their shares in BSE- Indonext model which provided a nation-wide trading platform for the investors of the company for their effective participation. They completed the up gradation of factory premises as per Revised Schedule M and started exporting their products to Asian African countries and Middle East countries.During the year 2009-10 the company acquired the certification for the registration with National Drug Authority Uganda wherein the company has got the eligibility to export their products to Uganda.During the year 2010-11 Vineet Laboratories Pvt Ltd a private limited company engaged in the manufacturing of Fine Chemicals Custom synthesis and specialized in making bulk drug intermediates for anti retrovirals and lipid lowering agents etc was amalgamated with the company. Also the company was allotted 6.18 acres of land in IDA Buchinelli Zaheerabad Medak Dist. AP by APIIC. The company is planning to construct USFDA and European Standard Bulk Drug manufacturing facility.In 2010-11 M/s. Vineet Laboratories Private Limited (VLPL) was merged with the Company through the Scheme of Amalgamation which was made effective from October 01 2010. In terms of the said Scheme of Amalgamation the Equity Shareholders of VLPL were entitled 17 Equity Shares of the Company for every 10 Equity Share held in Vineet Laboratories Private Limited. Thus 12240000 fully paid-up equity shares of Rs. 10/- each of the Company were issued and allotted to the equity shareholders of Vineet Laboratories Private Limited in the same proportion as to their shareholding in Vineet Laboratories Private Limited.In 2017-18 the scheme of arrangement between the Company and Vineet Laboratories Limited for demerger of the API Intermediates Division of the Company as a going concern was implemented.

Ortin Laboratories Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 10
Latest Dividend (%)2.50
Latest Dividend Date 24 Sep 2013
Dividend Yield (%) -
Book Value Share (₹) [S]12.00
P/B Ratio (₹) [S]1.66
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week-3.95%-4.55%0.000.03%
1 Month5.84%4.45%0.780.82%
3 Month-7.55%-7.85%2.312.85%
6 Month-3.99%-3.62%11.8013.77%
1 Year2.31%2.57%22.9426.43%
3 Year-12.50%-12.50%55.0557.36%

Company Info

Company Information

Managing Director : S Murali Krishna Murthy

Director : S Balaji Venkateswarlu

Whole Time Director & CFO : S Srinivas Kumar

Chairman & Independent Directo : J R K Panduranga Rao

Director : Gaddam Venkata Ramana

Director : Bhupathiraju S Raju

Independent Director : B Gopal Reddy

Independent Director : Murali Krishna Rayaprolu

Independent Director : Pottur Sujatha

Company Sec. & Compli. Officer : Divya Purswani

Registered Office: D No 1-8-B4 Ground Floor F3, HIG Block-4 Street No 3,Hyderabad,Telangana-500044 Ph: